House subcommittee schedules February hearings on user fees

01/12/2012 | Hill, The

A House Energy and Commerce health subcommittee will discuss the Prescription Drug User Fee Act on Feb. 1 and proposed user fees for biosimilars Feb. 7. The subcommittee also scheduled a hearing Feb. 15 on reauthorization of the FDA's user-fee program for devices.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY